Skip to main content
Melinda Pauly, MD, Pediatric Hematology & Oncology, Atlanta, GA

Melinda G Pauly MD

Pediatric Hematologic Oncology


Assistant Professor, Pediatrics, Emory University School of Medicine Medical Director of Oncology, Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta

Join to View Full Profile
  • 2220 North Druid Hills RdSouth Tower Cl15224Atlanta, GA 30329

  • Phone+1 404-785-3730

  • Fax+1 404-785-3600

Dr. Pauly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2009 - 2012
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Pediatrics, 2005 - 2008
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 2005

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2010 - 2025
  • AL State Medical License
    AL State Medical License 2007 - 2009
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

Abstracts/Posters

  • Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
    Melinda Pauly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Children’s Healthcare of Atlanta Opens First Clinical Trial for New Therapy Targeting Leukemia
    Children’s Healthcare of Atlanta Opens First Clinical Trial for New Therapy Targeting LeukemiaApril 12th, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: